CHEMED CORP (CHE) Stock Fundamental Analysis

NYSE:CHE • US16359R1032

473.06 USD
-0.16 (-0.03%)
At close: Feb 17, 2026
473.06 USD
0 (0%)
After Hours: 2/17/2026, 8:04:45 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

7

CHE gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. Both the health and profitability get an excellent rating, making CHE a very profitable company, without any liquidiy or solvency issues. CHE has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

  • In the past year CHE was profitable.
  • CHE had a positive operating cash flow in the past year.
  • Each year in the past 5 years CHE has been profitable.
  • CHE had a positive operating cash flow in each of the past 5 years.
CHE Yearly Net Income VS EBIT VS OCF VS FCFCHE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

1.2 Ratios

  • CHE's Return On Assets of 17.17% is amongst the best of the industry. CHE outperforms 100.00% of its industry peers.
  • CHE has a better Return On Equity (25.89%) than 91.18% of its industry peers.
  • CHE has a Return On Invested Capital of 21.27%. This is amongst the best in the industry. CHE outperforms 97.06% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for CHE is significantly above the industry average of 8.98%.
Industry RankSector Rank
ROA 17.17%
ROE 25.89%
ROIC 21.27%
ROA(3y)17.25%
ROA(5y)18.8%
ROE(3y)27.61%
ROE(5y)32.28%
ROIC(3y)21.96%
ROIC(5y)22.92%
CHE Yearly ROA, ROE, ROICCHE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

  • With an excellent Profit Margin value of 11.02%, CHE belongs to the best of the industry, outperforming 95.10% of the companies in the same industry.
  • CHE's Profit Margin has improved in the last couple of years.
  • Looking at the Operating Margin, with a value of 14.60%, CHE belongs to the top of the industry, outperforming 87.25% of the companies in the same industry.
  • CHE's Operating Margin has improved in the last couple of years.
  • With a decent Gross Margin value of 32.88%, CHE is doing good in the industry, outperforming 63.73% of the companies in the same industry.
  • CHE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 14.6%
PM (TTM) 11.02%
GM 32.88%
OM growth 3Y-0.29%
OM growth 5Y3.39%
PM growth 3Y-0.36%
PM growth 5Y1.83%
GM growth 3Y-0.79%
GM growth 5Y1.99%
CHE Yearly Profit, Operating, Gross MarginsCHE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CHE is creating value.
  • CHE has less shares outstanding than it did 1 year ago.
  • CHE has less shares outstanding than it did 5 years ago.
  • CHE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CHE Yearly Shares OutstandingCHE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
CHE Yearly Total Debt VS Total AssetsCHE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 12.23 indicates that CHE is not in any danger for bankruptcy at the moment.
  • CHE has a better Altman-Z score (12.23) than 96.08% of its industry peers.
  • The Debt to FCF ratio of CHE is 0.00, which is an excellent value as it means it would take CHE, only 0.00 years of fcf income to pay off all of its debts.
  • CHE has a better Debt to FCF ratio (0.00) than 93.14% of its industry peers.
  • A Debt/Equity ratio of 0.00 indicates that CHE is not too dependend on debt financing.
  • CHE has a better Debt to Equity ratio (0.00) than 85.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 12.23
ROIC/WACC2.45
WACC8.68%
CHE Yearly LT Debt VS Equity VS FCFCHE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 1.35 indicates that CHE should not have too much problems paying its short term obligations.
  • The Current ratio of CHE (1.35) is comparable to the rest of the industry.
  • A Quick Ratio of 1.33 indicates that CHE should not have too much problems paying its short term obligations.
  • CHE has a Quick ratio (1.33) which is in line with its industry peers.
  • The current and quick ratio evaluation for CHE is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.35
Quick Ratio 1.33
CHE Yearly Current Assets VS Current LiabilitesCHE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • CHE shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -3.97%.
  • The Earnings Per Share has been growing by 10.64% on average over the past years. This is quite good.
  • The Revenue has been growing slightly by 6.45% in the past year.
  • Measured over the past years, CHE shows a small growth in Revenue. The Revenue has been growing by 4.63% on average per year.
EPS 1Y (TTM)-3.97%
EPS 3Y6.14%
EPS 5Y10.64%
EPS Q2Q%-6.56%
Revenue 1Y (TTM)6.45%
Revenue growth 3Y4.36%
Revenue growth 5Y4.63%
Sales Q2Q%3.09%

3.2 Future

  • Based on estimates for the next years, CHE will show a small growth in Earnings Per Share. The EPS will grow by 6.76% on average per year.
  • Based on estimates for the next years, CHE will show a small growth in Revenue. The Revenue will grow by 5.01% on average per year.
EPS Next Y-3.31%
EPS Next 2Y5.31%
EPS Next 3Y6.13%
EPS Next 5Y6.76%
Revenue Next Year5.02%
Revenue Next 2Y5.54%
Revenue Next 3Y5.17%
Revenue Next 5Y5.01%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CHE Yearly Revenue VS EstimatesCHE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B 2.5B
CHE Yearly EPS VS EstimatesCHE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 10 20 30

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 21.50 indicates a rather expensive valuation of CHE.
  • Based on the Price/Earnings ratio, CHE is valued a bit cheaper than 67.65% of the companies in the same industry.
  • CHE is valuated rather cheaply when we compare the Price/Earnings ratio to 27.16, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 18.43 indicates a rather expensive valuation of CHE.
  • Based on the Price/Forward Earnings ratio, CHE is valued a bit cheaper than 65.69% of the companies in the same industry.
  • CHE is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 28.10, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 21.5
Fwd PE 18.43
CHE Price Earnings VS Forward Price EarningsCHE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as CHE.
  • Based on the Price/Free Cash Flow ratio, CHE is valued a bit cheaper than the industry average as 67.65% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 18.58
EV/EBITDA 15.15
CHE Per share dataCHE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150

4.3 Compensation for Growth

  • The excellent profitability rating of CHE may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2.02
EPS Next 2Y5.31%
EPS Next 3Y6.13%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.52%, CHE is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 0.48, CHE pays a better dividend. On top of this CHE pays more dividend than 81.37% of the companies listed in the same industry.
  • With a Dividend Yield of 0.52, CHE pays less dividend than the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 0.52%

5.2 History

  • On average, the dividend of CHE grows each year by 8.02%, which is quite nice.
  • CHE has been paying a dividend for at least 10 years, so it has a reliable track record.
  • CHE has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)8.02%
Div Incr Years16
Div Non Decr Years21
CHE Yearly Dividends per shareCHE Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

  • CHE pays out 11.01% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of CHE is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP11.01%
EPS Next 2Y5.31%
EPS Next 3Y6.13%
CHE Yearly Income VS Free CF VS DividendCHE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
CHE Dividend Payout.CHE Dividend Payout, showing the Payout Ratio.CHE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CHEMED CORP

NYSE:CHE (2/17/2026, 8:04:45 PM)

After market: 473.06 0 (0%)

473.06

-0.16 (-0.03%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-28
Earnings (Next)02-25
Inst Owners101.64%
Inst Owner Change39.85%
Ins Owners1.52%
Ins Owner Change-2.29%
Market Cap6.70B
Revenue(TTM)2.53B
Net Income(TTM)278.81M
Analysts82.5
Price Target566.61 (19.78%)
Short Float %4.66%
Short Ratio4.21
Dividend
Industry RankSector Rank
Dividend Yield 0.52%
Yearly Dividend1.83
Dividend Growth(5Y)8.02%
DP11.01%
Div Incr Years16
Div Non Decr Years21
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-8.99%
Min EPS beat(2)-15.11%
Max EPS beat(2)-2.88%
EPS beat(4)1
Avg EPS beat(4)-4.45%
Min EPS beat(4)-15.11%
Max EPS beat(4)0.5%
EPS beat(8)2
Avg EPS beat(8)-3.19%
EPS beat(12)4
Avg EPS beat(12)-2.23%
EPS beat(16)8
Avg EPS beat(16)-1.06%
Revenue beat(2)0
Avg Revenue beat(2)-1.85%
Min Revenue beat(2)-2.53%
Max Revenue beat(2)-1.17%
Revenue beat(4)0
Avg Revenue beat(4)-1.07%
Min Revenue beat(4)-2.53%
Max Revenue beat(4)-0.19%
Revenue beat(8)0
Avg Revenue beat(8)-1.28%
Revenue beat(12)2
Avg Revenue beat(12)-1.05%
Revenue beat(16)2
Avg Revenue beat(16)-1.24%
PT rev (1m)-3.27%
PT rev (3m)-3.98%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.01%
EPS NY rev (1m)-0.17%
EPS NY rev (3m)-0.06%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)0.14%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.04%
Valuation
Industry RankSector Rank
PE 21.5
Fwd PE 18.43
P/S 2.65
P/FCF 18.58
P/OCF 15.96
P/B 6.22
P/tB 20.63
EV/EBITDA 15.15
EPS(TTM)22
EY4.65%
EPS(NY)25.66
Fwd EY5.43%
FCF(TTM)25.46
FCFY5.38%
OCF(TTM)29.64
OCFY6.26%
SpS178.72
BVpS76.04
TBVpS22.94
PEG (NY)N/A
PEG (5Y)2.02
Graham Number194.01
Profitability
Industry RankSector Rank
ROA 17.17%
ROE 25.89%
ROCE 27.75%
ROIC 21.27%
ROICexc 23.56%
ROICexgc 62.89%
OM 14.6%
PM (TTM) 11.02%
GM 32.88%
FCFM 14.24%
ROA(3y)17.25%
ROA(5y)18.8%
ROE(3y)27.61%
ROE(5y)32.28%
ROIC(3y)21.96%
ROIC(5y)22.92%
ROICexc(3y)25.21%
ROICexc(5y)25.79%
ROICexgc(3y)67.33%
ROICexgc(5y)75.46%
ROCE(3y)28.73%
ROCE(5y)30.03%
ROICexgc growth 3Y-5.61%
ROICexgc growth 5Y0.34%
ROICexc growth 3Y-1.58%
ROICexc growth 5Y4.43%
OM growth 3Y-0.29%
OM growth 5Y3.39%
PM growth 3Y-0.36%
PM growth 5Y1.83%
GM growth 3Y-0.79%
GM growth 5Y1.99%
F-Score7
Asset Turnover1.56
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 92.02%
Cap/Sales 2.34%
Interest Coverage 250
Cash Conversion 96.74%
Profit Quality 129.28%
Current Ratio 1.35
Quick Ratio 1.33
Altman-Z 12.23
F-Score7
WACC8.68%
ROIC/WACC2.45
Cap/Depr(3y)89.59%
Cap/Depr(5y)94.39%
Cap/Sales(3y)2.41%
Cap/Sales(5y)2.56%
Profit Quality(3y)107.8%
Profit Quality(5y)110.23%
High Growth Momentum
Growth
EPS 1Y (TTM)-3.97%
EPS 3Y6.14%
EPS 5Y10.64%
EPS Q2Q%-6.56%
EPS Next Y-3.31%
EPS Next 2Y5.31%
EPS Next 3Y6.13%
EPS Next 5Y6.76%
Revenue 1Y (TTM)6.45%
Revenue growth 3Y4.36%
Revenue growth 5Y4.63%
Sales Q2Q%3.09%
Revenue Next Year5.02%
Revenue Next 2Y5.54%
Revenue Next 3Y5.17%
Revenue Next 5Y5.01%
EBIT growth 1Y-7.92%
EBIT growth 3Y4.05%
EBIT growth 5Y8.18%
EBIT Next Year14.67%
EBIT Next 3Y10.29%
EBIT Next 5Y9.62%
FCF growth 1Y39.38%
FCF growth 3Y13.77%
FCF growth 5Y8.19%
OCF growth 1Y30.35%
OCF growth 3Y10.6%
OCF growth 5Y6.75%

CHEMED CORP / CHE FAQ

What is the fundamental rating for CHE stock?

ChartMill assigns a fundamental rating of 7 / 10 to CHE.


What is the valuation status of CHEMED CORP (CHE) stock?

ChartMill assigns a valuation rating of 4 / 10 to CHEMED CORP (CHE). This can be considered as Fairly Valued.


Can you provide the profitability details for CHEMED CORP?

CHEMED CORP (CHE) has a profitability rating of 9 / 10.


Can you provide the financial health for CHE stock?

The financial health rating of CHEMED CORP (CHE) is 9 / 10.


What is the earnings growth outlook for CHEMED CORP?

The Earnings per Share (EPS) of CHEMED CORP (CHE) is expected to decline by -3.31% in the next year.